A detailed history of Louisiana State Employees Retirement System transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Louisiana State Employees Retirement System holds 35,100 shares of HALO stock, worth $1.69 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
35,100
Previous 36,000 2.5%
Holding current value
$1.69 Million
Previous $1.88 Million 6.58%
% of portfolio
0.04%
Previous 0.04%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$51.3 - $64.42 $46,170 - $57,978
-900 Reduced 2.5%
35,100 $2.01 Million
Q2 2024

Jul 24, 2024

SELL
$37.81 - $52.4 $75,620 - $104,800
-2,000 Reduced 5.26%
36,000 $1.88 Million
Q1 2024

Apr 23, 2024

BUY
$33.68 - $41.95 $30,312 - $37,755
900 Added 2.43%
38,000 $1.55 Million
Q4 2023

Jan 29, 2024

SELL
$33.32 - $42.1 $9,996 - $12,630
-300 Reduced 0.8%
37,100 $1.37 Million
Q3 2023

Oct 17, 2023

SELL
$36.46 - $44.03 $40,106 - $48,433
-1,100 Reduced 2.86%
37,400 $1.43 Million
Q2 2023

Jul 18, 2023

BUY
$30.28 - $38.74 $78,728 - $100,724
2,600 Added 7.24%
38,500 $1.39 Million
Q1 2023

Apr 19, 2023

SELL
$32.86 - $55.7 $9,858 - $16,710
-300 Reduced 0.83%
35,900 $1.37 Million
Q4 2022

Jan 24, 2023

SELL
$40.06 - $59.44 $20,030 - $29,720
-500 Reduced 1.36%
36,200 $2.06 Million
Q3 2022

Oct 19, 2022

BUY
$38.53 - $51.78 $19,265 - $25,890
500 Added 1.38%
36,700 $1.45 Million
Q2 2022

Jul 20, 2022

SELL
$37.35 - $48.3 $26,145 - $33,810
-700 Reduced 1.9%
36,200 $1.81 Million
Q1 2022

Apr 22, 2022

BUY
$31.97 - $41.06 $22,379 - $28,742
700 Added 1.93%
36,900 $1.6 Million
Q4 2021

Jan 14, 2022

SELL
$31.82 - $40.75 $3,182 - $4,075
-100 Reduced 0.28%
36,200 $1.46 Million
Q3 2021

Oct 12, 2021

BUY
$38.47 - $46.42 $61,552 - $74,272
1,600 Added 4.61%
36,300 $1.48 Million
Q2 2021

Jul 16, 2021

BUY
$38.84 - $51.31 $66,028 - $87,227
1,700 Added 5.15%
34,700 $1.58 Million
Q1 2021

Apr 14, 2021

BUY
$39.51 - $51.45 $47,412 - $61,740
1,200 Added 3.77%
33,000 $1.38 Million
Q4 2020

Jan 11, 2021

BUY
$25.81 - $43.62 $820,758 - $1.39 Million
31,800 New
31,800 $1.36 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.7B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Louisiana State Employees Retirement System Portfolio

Follow Louisiana State Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisiana State Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Louisiana State Employees Retirement System with notifications on news.